by Ekrem Duman | Aug 1, 2026 | Australia Company Stories, Healthcare & Biotech
⚡ TL;DRAustralia performs medical research substantially above its economic weight and captures a small share of the commercial value it creates. The pattern is consistent: publicly funded discovery in universities and medical research institutes, early-phase...
by Ekrem Duman | Aug 1, 2026 | Australia Company Stories, Healthcare & Biotech
⚡ TL;DRAustralia’s Pharmaceutical Benefits Scheme subsidises prescription medicines so patients pay a capped co-payment while the government pays the balance. Its defining feature is that listing requires a medicine to be assessed as cost-effective, not...
by Ekrem Duman | Aug 1, 2026 | Australia Company Stories, Healthcare & Biotech
⚡ TL;DRAustralian pathology and diagnostic imaging are dominated by a small number of large operators — Sonic Healthcare, Healius and Australian Clinical Labs among them — and the reason is operating leverage. A central laboratory carries high fixed...
by Ekrem Duman | Aug 1, 2026 | Australia Company Stories, Healthcare & Biotech
⚡ TL;DRCochlear and ResMed are Australia’s two great medical device companies, and both built the same business model from different starting points: sell a device that creates a lifelong patient relationship, then earn recurring revenue from that...
by Ekrem Duman | Aug 1, 2026 | Australia Company Stories, Healthcare & Biotech
⚡ TL;DRCSL began in 1916 as the Commonwealth Serum Laboratories, a government department created to make vaccines and antivenoms for a country too isolated to rely on imports. Privatised in 1994, it became one of the largest plasma therapeutics companies in the...
